Suppr超能文献

CMTM5对裸鼠移植人前列腺癌的抑制作用

[Inhibitory effect of CMTM5 on xenografted human prostatic cancer in nude mice].

作者信息

Xiao Yun-Bei, Xie Jing, Zhang Gou-Xi, Li Jing, Hao Yi-Chang, Zhang Xiao-Wei, Liu Zhen-Hua, Xu Tao, Wang Xiao-Feng

机构信息

Department of Urology, People's Hospital of Peking University, Beijing 100044, China.

出版信息

Zhonghua Nan Ke Xue. 2012 Mar;18(3):195-9.

Abstract

OBJECTIVE

To investigate the inhibitory effect of CKLF-like MARVEL transmembrane domain containing 5 (CMTM5) on xenografted human prostatic cancer in nude mice and its action mechanism.

METHODS

We established a model of xenografted prostatic cancer by inoculating PC-3 cells subcutaneously into nude mice, and 3 weeks later injected CMTM5 adenovirus locally into the tumor followed by daily observation of the tumor volume and body weight of the experimental animals. All the rats were killed 2 weeks after CMTM5 injection and the tumor tissue harvested for detection of the inhibitory effect of CMTM5 on the expressions of VEGF and NF-kappaB proteins by immunohistochemistry.

RESULTS

The tumor volume was significantly smaller and body weight of the CMTM5-treated mice were (573.39 +/- 175.24) mm3 and (0.55 +/- 0.11) g, respectively, significantly decreased as compared with those of the controls ([1482.50 +/- 327.86] mm3 and [1.31 +/- 0.29] g) (P = 0.03 and P = 0.027). Immunohistochemistry showed that the expressions of VEGF and NF-kappaB were obviously down-regulated in the CMTM5 group in comparison with the control group.

CONCLUSION

CMTM5 suppresses the growth of prostate cancer by down-regulating the expressions of VEGF and NF-kappaB.

摘要

目的

探讨含CKLF样MARVEL跨膜结构域5(CMTM5)对裸鼠人前列腺癌移植瘤的抑制作用及其作用机制。

方法

将PC-3细胞皮下接种于裸鼠建立前列腺癌移植瘤模型,3周后将CMTM5腺病毒局部注射到肿瘤内,随后每天观察实验动物的肿瘤体积和体重。注射CMTM5后2周处死所有大鼠,取肿瘤组织,通过免疫组化检测CMTM5对VEGF和NF-κB蛋白表达的抑制作用。

结果

CMTM5处理组小鼠的肿瘤体积明显较小,体重分别为(573.39±175.24)mm³和(0.55±0.11)g,与对照组([1482.50±327.86]mm³和[1.31±0.29]g)相比显著降低(P = 0.03和P = 0.027)。免疫组化显示,与对照组相比,CMTM5组VEGF和NF-κB的表达明显下调。

结论

CMTM5通过下调VEGF和NF-κB的表达抑制前列腺癌的生长。

相似文献

2
CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
Clin Transl Oncol. 2015 Jun;17(6):431-7. doi: 10.1007/s12094-014-1253-z. Epub 2014 Nov 12.
3
CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12533. Epub 2021 Nov 18.
4
[Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Dec;34(6):625-8. doi: 10.3881/j.issn.1000-503X.2012.06.018.
5
CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
Biochem Biophys Res Commun. 2014 May 2;447(2):304-10. doi: 10.1016/j.bbrc.2014.03.158. Epub 2014 Apr 8.
6
CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
Clin Cancer Res. 2007 Oct 1;13(19):5756-62. doi: 10.1158/1078-0432.CCR-06-3082.
8
[CMTM5 inhibits the tumor cell behavior of prostate cancer by downregulation of HER2].
Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Aug 18;42(4):386-90.
10
Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
Leuk Res. 2011 Jun;35(6):771-6. doi: 10.1016/j.leukres.2010.11.023. Epub 2010 Dec 18.

引用本文的文献

1
Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
Int J Biol Sci. 2019 Sep 7;15(12):2576-2583. doi: 10.7150/ijbs.33733. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验